Skip to content

Microecology and Host Immunity in Patients With Severe COVID-19 Infection

Microecology and Host Immunity in Patients With Severe COVID-19 Infection

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05670275
Enrollment
200
Registered
2023-01-04
Start date
2022-12-01
Completion date
2023-06-30
Last updated
2023-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microbiome,Immune Function, Critically Ill

Brief summary

The purpose of this study was to analyze the relationship between the microbial community, host immunity and the prognosis of patients with severe COVID-19.

Detailed description

Methods: Bronchoalveolar lavage specimens of patients with severe COVID-19 were collected and studied to analyze the relationship between the composition of patients' microecology and the occurrence and development of disease.

Interventions

None listed

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years

Inclusion criteria

* 1\) Respiratory distress, respiratory rate ≥ 30 times/minute 2\) At rest, oxygen saturation ≤ 93% 3)PaO2/FiO2 ≤300mmHg 4\) Shock 5\) Respiratory failure requires mechanical ventilation 6\) Complicated with other organ failure requires ICU monitoring and treatment 7\) Or in case of any of the following conditions, even if none of the above conditions is found, it is also managed as a critical case: ① pulmonary imaging shows that the lesion has significantly progressed more than 50% within 24-48 hours; ② Age\>60 years old; ③ Complicated with serious chronic diseases (including diabetes, hypertension, coronary heart disease, malignant tumor, structural lung disease, pulmonary heart disease and immunosuppressed population)

Exclusion criteria

* 1\) Pregnant women 2\) Age\<18 3\) Mental disorders 4\) Patients with long-term mechanical ventilation for more than 60 days 5\) Disagreement group researcher

Design outcomes

Primary

MeasureTime frameDescription
death28 daymortality

Countries

China

Contacts

Primary ContactLin Wang, doctor
wl1194079931@163.com15822048750

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026